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CHAPTER I 
INTRODUCTION 
No disease so uniformly affects the,microvasculatuie as diabetes 
mellitus. The chronic degenerative disease of the microvascular system 
which occurs in diabetes mellitus was first recognized over a century ago 
[reference cited in 71]. Elucidation of the nature of diabetic micro-
angiopathy was extr~mely slow until the discovery of insulin in 1922. 
The advent of insulin therapy brought a lohger life after the onset of 
measurable biochemical abnormalities. Consequently, more extensive vascular 
disease has developed, so that today 85% of the people with diabetes 
mellitus die from the cardiovascular-renal complications of diabetic 
microangiopathy rather than from ketoacidosis, insulin shock and other 
related conditions. 
The microvascular manifestations of ~iabetes mellitus represent 
a far more serious aspect of this disease than do the carbohydrate 
derangements. "Tightly controlled" diabetics develop vascular problems 
as readily as insulin-iridependent diabetics' [91]. Yet little is known 
about the basic pathogenesis of diabetic micro:mgiopnthy. Hith recognition 
of the importance of diahctlc m:Lcroangiopathy, there is an appreciation 
of the need to evaluate quantitatively how diabetes mellitus alters 
microcirculatory phenomena. 
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The purpose of this study was to evaluate quantitatively the 
microcirculation in an animal model of diabetes mellitus. Specifically, 
the red cell velocity in mesenteric microvessels, i.e., arterioles, 
capillaries and venules, .vere measured in non-diabet~c and streptozotocin-
diabetic rats. 
CHAPTER II 
LITERATURE REVIEW 
A. PHYSICAL AND CHEMICAL ALTERATIONS OF THE CAPILLARY BASE"t-1ENT NEHBRANE 
IN DIABETES HELLITUS 
1. Physical Changes in the Diabetic Capillary Basement Membrane 
The term "diabetic microangiopathy" denotes the chronic, degen-
erative vascular disease of the smallest blood vessels throughout the 
body in diabetes mellitus [24, 30, 54, 79]. Using histochemical techniques, 
light microscopic examination of various tissues revealed the presence of 
increased amounts of periodic acid-Schiff (PAS) positive material in the 
vessel walls of arterioles, capillaries and venules [30, 39, 65, 79, 107]. 
Basement membranes are extra-cellular structures that rea~t intensely 
with periodic acid-Schiff stain. On the basis of light microscopic studies, 
Friedemvald [ 34, 35] suggested that a specific thickening of the capillary 
basement membrane contributed to· the microvascular complications of diabetes 
mellitus. Electron microscopy provided the technology with which the 
validity of this suggestion could be examined. 
The basement membrane located under the endothelium of blood vessels 
appears as an electron dense feltwork of fine fibrils when seen on electron 
micrographs [58]. It is usually only a few hundred angstroms in width [79]. 
When the same localization is demonstrated with PAS staining techniques 
<1nd vll'\vC'd wlt:h <1 Light microscope, i L <1ppc;Jrs ns <1 homogeneous structure 
and measures about 1 to 2 microns in width [79]. The basement membrane 
seen on light microscopy and electron n1icroscopy are two different things. 
-3-
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The first electron microscopists simply borrm.;red a term in common usage 
among light microscopists. 
· Electron microscopy was used extensively by Siperstein et. al. [92] 
and Williamson and his group [53, 123] as a tool for quantitatively as-
sessing basement membrane thickening in diabetics. Their anatomical 
studies demonstrated that a segmental thickening of the capillary basement 
membrane is the'morphological feature which best characterizes diabetic 
microangiopathy [53, 124]. Arterioles and venules may be similarly affected 
[30, 122]. Other investigators reported similar observations in such 
diverse tissues as skin [1, 65, 79], muscle [53, 79, 92, 115, 116], retina 
[8, 79) and kidney [7, 32, 78, 79]. This suggests that thickening of the 
capillary basement membrane may be a generalized phenomenon involving small 
blood vessels throughout the body [30, 54, 71, 96, 107, 124]. 
While thickening of the capillary basement membrane is generally 
actepted as one of the first manifestations of diabetic microangiopathy, 
the electron microscopic observations have become disputed in two areas. 
These are: (1) the time of the occurence of thickening in relation to 
the onset of carbohydrate derangements and (2) whether basem-ent membrane 
thickening progresses with duration of diabetes. Siperstein proposed that 
basement membrane thickening occur's before the onset of diabetes and may 
be the cause and not the consequence of diabetes. ¢sterby-Hansen [78] 
found that diabetic microangiopathy and tliickenlng of the basement membrane 
do not. occur in the glomeruli of young diabetics of recent .onset. This 
indicates that early changes in prediabetes is unlikely. Williamson [53] 
suggests that the basement membrane ~Vidth of muscle capillaries is normal 
in most individuals prior to the onset pf carbohydrate intoleranc~. 
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According to Pometta et. al. [82] there is no significant increase in th~ 
--- -
basement membrane width of muscle capillaries in potential diabetics or 
diabetics of recent onset as compared to non-diabetic control subjects. 
Siperstein [92] has reported that no relationship exists between 
the duration and severity of diabetes and the width of the capillary 
basement membrane. If generalized basement membrane thickening precedes 
carbohydrate intolerance, then basement membrane thickening should be found 
in all diabetics. That_Williamson [125] found basement membrane thickening 
i11 less than one third of insulin-dependent diabetics who have had their 
disease less -than four years, coupled with a highly significant increase 
in the incidence of basement membrane thickening with increased duration 
of carbohydrate intolerance supports the concept that basement membrane 
thickening is a consequence of the carbohydrate intolerance associated 
with diabetes. 
The disparate results responsible For the controversy regarding 
the incidence arid significance of capillary basement membrane thickening 
in diabetes mellitus can be reconciled on the basis of the following: 
(1) methods of fixation and measurement technique [52, 94, 120, 123, 125]; 
(2) artifacts related to criteria for selection of subjects [52, 120, 125]; 
(3) sample size [52, 120]; and (4) the use of age and sex adjusted normal 
confidence limits in assessing basement membrane thickening. 
]:_. ___ C~1 em lc al~h[:!..!_"l_f,_~~s_:~~-~1_l~-~iah_~t_:_~c __ _£~"l_E.:! 11 rl_!Y _ _Ba ~~'me_J_~~-ll~'_m h filn e 
The periodic acid-SchHf staining technique is very discriminating 
in detcct:inr, glycoproteins in tiss11e sections [81, 99, 107]. B<1scment 
membranes react intensely with PAS stain. This indicates their glyco-
protein nature [101]. Compositional analyses of basement membranes have 
supported the histochemical evidence concerning their glycoprotein nature 
[ 101' 105] . 
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On the hasis of histochemical evidence it was postulated th<1t 
diabetic microangiopathy resulted from a disturbance in the metabolism 
of the carbohydrate containing proteins [35]. Studies of the glomerular 
basement membrane in human diabetes indicated that the total amount of 
membrane present is increased and furthermore that a distinct chemical 
alteration occurred [5, 6, 57]. The chemical alteration in the basement 
membrane was found to specifically involve an increased amount of hydroxy-
lysine and a similar elevation in the number of hydroxylysine attached 
glucosylgalactose disaccharide units. 
Spiro proposed a·sophisticated hypothesis to explain the alteration 
in chemical composition [104, 105]. He found that the level of kidney 
glucosyltransferase, an enzyme involved in the synthesis of the hydroxy-
lysine-linked disaccharide units of the glomerular basement membrane, was 
significantly elevated in alloxan diabetic rats when compared to age 
. matched controls [102]. He suggested that the elevation of carbohydrate 
content in the diabetic glomerular basement membrane is not simply due 
to an increased attachment of glucosylgalactose disaccharide units to 
unsubstituted ·hydroxylysine residues. In the normal glomerular basement 
membrane, all sterically available hydroxylysine residues are glycosylated 
[103]. Spiro [104, 105] postulated that the increase in the carbohydrate 
content of the diabetic glomerular basement membrane is due to a preferential 
production of subunits rich in hyclroxylyslnc, r;1thcr thnn to ;m :incrcnsc 
ln hydroxyl<1tion of lysitw residues <1 Lre;1cly present. These newly formed 
!tvdn>xvlv.!;lm' t't'sldttt's <II"L' ~;uhc;t'CfltL'ttlly glyt't>!;yl:tt t'd. 
The validity of this hypothesis was challenged by Kcfalides [51] 
and Westberg nncl Hiclw.el r12·0]. These investigators have performed 
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compositional analyses on the ht~an diabetic glomerular basement membrane 
with variable results. Westberg and Michael [120] found that the most 
distinct difference in the amino acid composition between glomerular 
basement membranes from normal and diabetic kidneys was the decrease in 
the half cystine content of the diabetic kidneys. Contrary to the findings 
of Beisswenger and Spiro [6], they found no increase in the amounts of 
hydroxylysine or in the number of glucosylgalactose disaccharides lipked 
to this amino acid. Kefalides [51] found no difference in the half cystine 
content of normal and diabetic glomerular basement membranes. His data 
demonstrated that the amino acid and carbohydrate compositions of the 
diabetic glomerular basement membrane are very similar to those of the 
normal glomerular basement membrane·. 
Spiro [105] has pointed out a number of pitfalls to be avoided in 
compositional analyses of glomerular basement membranes. The kidneys ·to 
be analyzed for chemical changes must be limited to those showing micre-
scopic evidence of glomerular pathology. Care must be taken that patho-
logical glomeruli are isolated and that the preparation is not contaminated 
with cell membranes. The pathological changes in the kidneys used by 
Westberg and Michael [120] and Beisswenger and Spiro [5, 6] were compatible 
with diabetic kidney disease. Differences in the purity of the glomerular 
basement membrane preparations could possibly explain the,discrepancy 
between the results of Westberg and Michael [120] and those reported by 
Beisswcnger and Spiro [5, 6]. Kefalidcs [51] does not give any information 
about the presence or absence of glomerular pathology in the kidneys he 
used in performing l1is compositional analyses. In addition, his preparations 
were probably contaminated ~vi th cell membranes. 
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3. SurnmaD::_ of 13<Jscment 1-Jcmbranc Alterntions in Diabetes Hellitus 
Studies of ndcrovessels in diabetes in the last fifteen years 
have concentrated heavily on the anatomic and biochemical abnormalities 
of the capillary basement membrane [5, 6, 52, 53, 57, 71, 78, 79, 82, 92, 
94, 104, 105, 115, 116, 123, 124, 125]. The anatomical studies demonstrated 
that a segmental thickening of the capillary basement membrane character-
istically occurs in diabetics. The biochemical studies suggest that the 
chemical structure of the basement membrane may be altered. Controversy 
has developed about both of these changes. This has had th~ unplanned 
effect of diminishing attention to the ov~rall goal, i.e., elucidation 
of the relationship between the insulin-deficient state and the development 
of the microvascular concomitants of diabetes mellitus. It remains to be 
established how these anatomic and biochemical changes influence the 
physiologic role of the capillary basement membrane as a supportive structure 
and selective filter. 
B. PERNEABILITY OF SHALL VESSELS IN DIABETES HELLITUS 
The periendothelial deposition of PAS(+) material and the pronounced 
thickening of the capillary basement membrane in diabetic microangiopathy 
has implications for transcapillary transport. Westberg and Michael [120] 
and Spiro [5, 100, 103~ 104] have suggested that the changes they find in 
the chemical composition of the glomerular basement membrane could alter 
the porosity of the membrane. This would be due to the compositional 
ch<Jngcs affecting cross-links between peptide chains or by sterically 
interfering with their packing. 
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~-J'-~rmeab:iJ_~:_ Skeletal___k1uscle Capil_laries 
Various investigators [2, 80, 110, 111, 112, 113, Uff] studied. 
the transfer of electrolytes and large molecules across the capillary 
n!embrane between the vascular compartment and the interstitial compartment 
of skeletal muscle in long-term (>10 years) and short-term (<5 years) 
juvenile diabetics. Their findings suggest that the skeletal muscle cap-
illaries of long-term diabetics are more permeable. This increase in· 
permeability was attributed to an increase in the diameter of the intra-
c~llular cleft from 40 to 50 angstroms [114]. It was not attributed to 
an increase in the porosity of the basement membrane or to an increase in 
the area of the exchange surface [ 2] . The thickened capillary basement· 
membrane is not the rate limiting factor in the transcapillary exchange 
process in ske~etal muscle. 
2. Permeability of Glomerular Capillaries 
The basement membrane surrounding glomerular capillaries is regarded 
.as the main filter preventing.passage of large molecules in the kidney. 
A more direct application of the theories of molecular sieving is possible 
in the glomerulus. The filtration rate can be determined with a high 
~egree of accuracy and complete collection of the filtered macromolecules 
is possible if insignificant tubular reabsorption takes place. The sug-
gestion that changes in the chemical composition of the glomerular basement 
membrane alters the porosity of the membrane [5, 6, 100, 103, 104, 105, 
120] ought to he studied in the kidney r:1ther th:1n in skclct<ll mnsc1e. 
C.E. 1·1ogcnsen [72, 73, 74] studied the glomerular filtration rate 
(GFR) and glomerular permeability to macromolecules in newly diagnosed, 
untreated juvenile diabetics and in short-term and long-term juvenile 
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di~betics. He found that the GFR was increased 41% in the newly diag-
nosed, untreated diabetics when compared with age matched controls [74]. 
131 The renal plasma flows obtained by PAH and I-hippuran clearances were 
not different from normal values. If a more porous basement membrane was 
responsible for the increase in GFR, then the clearance of larger molecula-r 
weight dextrans should increase. :Hogensen [72, 73] found no evidence to 
indicate this. H.ogensen [74] also found that the GFR decreased as the 
duration of diabetes increased. This is not consistent with the suggestion 
of Westberg and Michael [120] or Beisswenger and Spiro [5, 6] that changes 
in the chemical composition of the glomerular basement membrane alters 
its porosity. 
3. Summary of Permeability Changes in Diabetic Capillaries 
The permeability studies of skeletal muscle and glomerular capillary 
basement membranes strongly suggest that ,the thickened basement membranes 
of diabetics do not hinder transcapillary exchange processes. The glom-
erular permeability to macromolecules does not indicate that the porosity 
of the glomerular basement membrane is increased. Therefore, any change 
in the chemical composition of the diabetic basement membrane does not 
result in a structural defect that alters its role as a selective filter. 
C. FUNCTIONAL DIABETIC MICROANGIOPATHY 
The structural abnormalities characterisric of diabetic micro-
angiopathy· Here dcmonstr~1tcd t:o occur at <l L1tcr stage in the evolution 
of the disease [71]. Functional abnormalities were obseryed in several 
vascular beds 'prior to the appearance of any clinical signs of micro-
angiopathy [30, 31, 54]. One manifestation of this functional microangiopathy 
is that alterations in blood flow precede structural changes in blood vessels~ 
-11_: 
1. · Blood Flow Changes in Diabetes Hell it us 
The gross blood flow has been studied in various vascular beds 
of hwnan diabetics [2, 11, 18, 36, 38, 40, 55]. The vascular beds studied 
include the skin [36, 38], retina [55], abdominal subcutaneous adipose 
tissue [38, 40], and skeletal muscle in the forearm [11, 18, 38, 40] and 
calf [2]. The techniques used for flow measurement include isotope clear-
ance [2, 36, 38, 40], fluorescein angiography [55], mercury-in-rubber 
strain gauges and venous occlusion plethysmography [2, 11, 18, 36, 38]. 
A high resting blood flow has been found in the retina [55] and 
forearm [11] of diabetics with no or .only mild microangiopathy. Furthermore, 
it was demonstrated that the elevated blood flow declined towards normal 
as the microangiopathic lesions progressed to severe levels. Christensen 
[18] demonstrated that the resting forearm blood flow to be increased in 
newly diagnosed, untreated juvenile diabetics. 
Alpert ~· al. [2] used venous Gcclusion plethysmography to determine 
resting blood flow in normal persons and patients with prediabetes and 
diabetes with nnd without ·microangiopnthy. No significant' differences 
in resting calf blood flow were found between the groups. This finding 
does not support the work of Butterfield and Holling [13], Christensen [18] 
and Kohner~_!· al. [55]. It is supported by the work o.f Greeson et. al. 
[36]. Using plethysmographic.techniques to study blood flow in th~ calf, 
they found no diffprence in blood f1ow hett.;ecn cllnhctics nncl nnnnnl controls. 
In~~· cnmp:11~Lson of tilL' abdomfn:ll suhcut::liH'OU~; [at tissue blood 
flow in healthy individuals and in diabetics made be Haggendal ~· al. [ 40], 
it 1ms demonstrated tlwt the average blood flow wns higher in clinhetics 
than in healthy individuals. Administration of insulin·to the diabetics 
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lowered the blood flow. The relationship between elevated peripheral 
blood flow and metabolic control \vas investigated by Gunderson [ 38]. 
Previously insulin-treated patients, in whom insulin was withdrawn for a 
few days, showed elevated blood flow in the forearm, subcutaneous abdominal 
fat tissue and skin. A group of newly diagnosed, non-treated diabetic 
patients showed elevated blood flow only in the subcutaneous abdominal fat 
tissue and skin. During periods of .good metabolic control, the diabetics 
had normal values for forearm, sub~utaneous abdominal fat tissue and skln 
blood flow. 
2. Changes in Blood Vessel Responsiveness 
In conjunction with the altered blood flows, the responsiveness 
of diabetic blood vessels to various stimuli was found to be abnormal [18, 
36, 40]. Greeson~·~- [36] demonstrated an impaired ability of diabetic 
cutaneous blood vessels to respond to dilating stimuli. If the resistance 
vessels were maximally dilated when the stimulus was applied, then the 
results could be falsely interpreted as a diminished vascular reactivity. 
Without quantitatively measuring the dimensions of the cutaneous vessels 
when the dilating stimuli \\'as applied, no direct assessment of vascular 
reactivity can be made. 
These studies were performed using plethysmographic techniques. 
This measures both skin and muscle blood flow. A technique that measures 
cutaneous blood flow independently of mus4le blood flow would have been 
mo~c appropriate for assessing tlte reactivity of cutaneous blood vessels 
to dilating stimuli. Greeson et. al. did use an isotope clearance tech-
nique to measure resting skin blood flow. They did not use this method 
to test the responsiveness of the cutaneous vasculature to dilating stimuli. 
- L3-
Christensen [18] investigated abnormal vascular function in a 
group of short-term ~iabetic patients. The rate 6£ return of blood flow 
towards basal levels following reactive hyperemia was determined before 
treatment or after withdrawal of insulin· and again after insulin treatment. 
In the diabetic patients peak flow was greater than in the non-diabetic 
controls. No significant differ-ence was seen before or after insulin 
treatment. Reactive hyperemia was found to be consid€rably prolonged in 
the diabetic patients. This abnormality disappeared after insulin treat-
ment. 
The maximum blood flow in the anterior tibial muscle during rea.ctive 
hyperemia following ischemia and exercise has been measured by various 
investigators with· conflicting results. Trap-Jensen and Lassen [110] and 
Trap-Jensen ~· al. [111] found no significant difference in the maximal 
hyperemic muscle blood flow within the groups (~on-diabetic, recently 
diagnosed and long-term diabetics) studied. Using identical techniques, 
Alpert~· al. [2] found normal persons had hyperemic muscle flows signif-
icantly greater than those in prediabetics or diabetics with and without 
microangiopathy. No differences were found betw.een the prediabetic and 
diabetic groups. The hyperemic muscle blood flo~s in the prediabetic and 
diabetic groups were identical with those reported by Trap-Jensen and 
Lassen [110] and Trap-Jensen.et. al. [111] for their non-diabetic, recently 
di<tRnoscd and long-term dinhct:ic. p:tt:ients. 
Qualitative descriptions-of the bulbar conjuctiva in diabetics 
were carried out by Ditzel and his co-workers using tltc biomicroscope 
combined with a flash photographic technique [25, 26, 27, 28, 30]. The 
most consistent observation was the pathological formation of erythrocyte 
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aggregations. A reduction in the velocity of flow was associated with 
the formation of erythrocyte aggregates. This created a condition which 
favored microthrombus formation and deposition of carbohydrate-lipid-
protein complexes in the walls of small blood vessels. 
3. Summary of Changes in Blood Flow and Blood Vessel, Responsiveness 
The exact role of altered blood flow in producing microangiopathy 
is not clear. Only by adequately defining the degree of microangiopathy 
and the deg!ee of metabolic control can this be established. In the gross 
bloGd flow studies the degiee of metabolic control has been either abnormal 
[11, 18, 40] or not described [2, 36, 55]. In addition, the degree of 
microangiopathy was either not stated [18, 38] or diabetics without evidence 
of microangiopathy,were grouped with diabetics with evidence of micro-
angiopathy. 
Vasodilatation and/or an el~vated blood pressure could be responsible 
for the increase in blood flow observed in diabetics. As vessel dimensions 
and blood pressure were not quantitatively measured in these studies, the 
mec-hanisms responsible for the elevated blood flow are not known. The 
same arguments are applicable to the mechanisms responsible for return of 
blood flo~ towards normal in satisfactorily controlled cliab~tics and in 
diabetics with progressively worsening microangiopathy. 
The exact relationship between altered blood flow, abnormal vascular 
reactivity and diabetic microangiopathy ii not clear. The failure of 
investigators to define exactly the state of metabolic control .:ll1d the 
presence of microangiopathic lesions has left the issue muddled. The 
investigations of Christensen [18] and Gunderson [38] definitely suggest 
insulin alters ;he ability of blood vessels to regulate their tone. No 
-.1:5-
investigations where direct quantitative measurements of blood flow in 
microvessels, i.e., arterioles, capillaries and vemtles have been conducted. 
Therefore, the relationships between the insulin-deficient state, abnormal 
vascular-function and thickening of the capillary basement membrane remain 
speculative. 
D. BIOCHEHICAL AND PHYSIOLOGICAL ALTERATIONS OF DIABETIC BLOOD 
1. Changes in Serum Protein Composition 
The blo6d vessels are not the only componen~ nf the circulatory 
system to be biochemically and physiologically altered in diabetes mellitus. 
The blood also undergoes biochemical and physiological alterations. In 
addition to hyperglycemia, there are changes in the plasma concentrations 
of the circulating protein-bound carbohydrates, protein.s and lipids. 
Characteristically, a decrease in serum albumin, accompanied by an increase 
in the a- and S-globulin$ was observed [9, 27, 66, 69, 70, 88]. Winzler 
[127] has reviewed the considerable wealth of data in the literature 
substantiating this observation. It was suggested, but not proven, that 
these changes precede the degenerative alterations in blood vessels [88]. 
2. Abnormal Blood Viscosity in Diabetes Hellitus 
The blood proteins impart ·a significant influence on the rheological 
characteristics of circulating blood [~7, 67, 121]. Hodifications in the 
plasma pr~tein distribution may have considerable bearing on the viscous 
behavior of blood in the various microvascular compartments, i.e., arterioles, 
C<lpf.l.J;Jr.iL'~; :ltHJ Slll<lll Vl'llll]c:.;, <IS \1/l'il <IS Oil lhl' dcv<'lnpmt•nt nf t"IH' dl'gl'll-
erative cl1anges in the smaller blood vessels of individuals with diabetes 
[69J. Blond viscosity c;m only he of :lmporlnncc in the development of 
microangiopathy if blood viscosity is altered before the occurence of 
microangiopathic lesions. 
-16-: 
In vitro studies of the rheological properties of human diabetic 
blood ,and· serum have yielded conflicting results, both in regards to 
changes in diabetes and about the relation of viscosity to diabetic micro-
angiopathy. Cogan~· al. Il9] first published evidence of serum viscosity 
elevation in diabetes mellitus. However, serum viscosity was not greater 
in diabetics with microangiopathy than in those without microangiopathy. 
Studies of diabetic patients without evidence of vascular complications 
by Ditzel~[29] demoDstrated no significant differences in whole blood 
.viscosity betwee~ diabetic and non-diabetic patients. Similar studies 
with more accurate viscometers have indicated that blood and serum viscosity 
are both elevated in diabeti~s [19, 45, 67, 69, 70, 95]. The viscosity 
is even more strikipgly increased in diabetics with evidence of microangiopathy 
[45, 67, 69, 70], and especially at low .shear rates 143]. 
Over the years the increased serum viscosity might favor the 
development of diabetic microangiopathic lesions. Despite quantitative 
differences in the degree of viscosity elevation, the hyperviscosity syndromes 
share such features as retinal changes, neurological disorders and glom-
erular basement membrane thickening with diabetic microangiopathy [71, 119]. 
MicrQaneurysms, hemorrhages and retinal vein dilatation have been found· in 
macroglobulinemia [4, 32] and myelomatosis [56]. Both are conditions in 
which.the blood viscosity is raised. Microangiopathic lesions have been 
produced experiment~lly by increasing the ~lood viscosity with dextran [63]. 
3. Summary of lliochcmical and Physiolog:Lc.:1l Alterations of Diclhctic 
Blood ~--~~-----------------------
Conclusions about the rheology of blood in the microcir~ulation can 
only be based on inferences from the physical characteristics of blood with-
drawn from the macroc'irculation but analyzed in an in vitro system .which 
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may not represent the J-n :'ivo situation. \,fithout knowledge of the shear 
stresses and .shear rates existing in the microcirculation, extrapolation 
from the in vitro conditions of a viscometer to conclusions about the 
hemodynamic significance of viscosity in the microcirculation cannot be 
made. Silent testimony to the difficulty of making .in vivo measurements 
of shear stress and shear rate for blood ln the microcirculation is found 
in the absence of such data in the literature .. However, information of 
this nature would derive from quantitative measurement of microvessel blood 
flow. 
E. SUMHARY OF LITERATURE REVIEW AND STATEHENT OF PURPOSE 
Thickening of capillary basement membranes has emerged as the 
fundamental morphologic alteration characteristic of diabetic microangiopathy 
[53, 91, 123, 124]. Although the microangiopathy of the the retina and 
kidneys has traditionally received great attention, rece~t studies have 
shown that most, if not all, capillary beds of the body are affected [30, 
54, 71, 96, 107, 124]. The ubiquitous nature of diabetic microangiopathy 
suggests that the formation of microangiopathic lesions is relatively 
independent of extravascular metabolic processes. It is unlikely that 
an extravascular metabolic process unique to a single organ is responsible 
for the accumulation of PAS positive material in the vessel walls of 
arterioles, capillaries and venules. This indicates a change in the blood 
may play a role in the development of diabetic microangiopath~. 
Changes in plasma protein composition are known to occur in diabetes 
mellitus [127]. Both increased pL1sma v:iscosity ;mel· enh;mced JntrovascuL1r 
aggregation have been related to the same changes in plasma protein compo-
. . 
sition [27, 69, 70]. The circulatory problem in diabetes mellitus is 
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confined mainly to the capillaries and small venules; hence, this is t:he 
level of the circulation where intravascular rheology requires analysis 
in this disease. Therefore, information about diabetic microangiopathy 
will result from techniques which provide for direct·in vivo quantitation 
of blood flow in microvessels. 
The purpose of this study was to evaluate quantitatively the 
microcirculation in an animal model of diabetes mellitus. Specifically, 
the red cell velocity in mesenteric microvessels, i.e., arterioles, cap-
illaries and venules, were measured in non-diabetic and streptozotocin-
diabetic rats. 
CHAPTER III 
HETHODS 
A. ANIHALS AND CARE 
Adult male Holtzman rats (>60 days old) were used in this study. 
0 They were acclimated to the temperature (76±2 F) and the light period 
(7 AH to 7 PM) in the animals quarters for at least one week before use. 
Laboratory chow and water were provided ad libitum. Prior to an experiment, 
the animals were fasted overnight. This consisted of removing food, but 
not water, from the animals at approximately 6 PM on the evening immediately 
preceding an experiment. 
B. INDUCTION OF DIABETES MELLITUS AND EVALUATION OF THE DIABETIC STATE 
Streptozotocin (Upjohn Co., Kalamazoo, Hichigan) was used to induce 
diabetes mellittts in fed male Holtzman rats. The rats were anesthetised 
with sodium pentobarbital (1.6 mg, i.p.) to facilitate rapid handling. A 
solution of streptozotocin (100 mg/dl) in citrate buffer (0.1 M in 0.9% 
saline) was made not more than 2.5 minutes before an intravenous injection 
of streptozotocin (25 mg) was given into the dorsal vein of the penis. At 
the time of injection these rats were 12 weeks old and of a mean body weight 
of 330 grams. 
The polydipsia, polyphagia and polyuria evident "in these rats during 
the weeks followLng the streptozotocin treatment <JS well as their weight 
loss and emaciated appearan~e suggested a diabetic state. Only those rats 
whose plasma glucose concentration following an overnight fast was greater 
than 140 mg/dl were used. A Yellow Springs Instrument Hodel 23A Glucose 
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Analyzer was used to measure plasma glucose concentrations. The blood 
s~mple was obtained from the left carotid artery on the day of the exper-
iment. 
The effect of streptozotocin-diabetes on the microcirculation was 
assessed by measuring the red cell velocity in the mesenteric microvessels 
of three groups of rats. One group of rats was not treated with strepto-
zotocin. They served as age-matched, normal controls. The streptozotocin-
treated animals were divided into two g~oups: a short-term and a long-term 
diabetic group. The rats in the short-term diabetic group served as hyper-
glycemic controls. Experiments conducted on control animals were inter-
spersed with those conducted on the streptozotocin-tre~ted animals. 
C. SURGICAL PROCEDURE 
Fasted male Holtzmann rats were anesthetized with sodium pentobarbital 
(35 mg/kg, i.~.). The abdomen and ventral aspect of the neck were shaved in 
preparation·for surgery. 
The right jugular ve:i,n \vas cannulated (PE-50, Clay-Adams) for the 
intravenous administration of maintenance doses of anesthesia. A second 
PE-50 catheter was placed in the left carotid artery and coupled to a 
Statham P23Gb pressure transducer for arterial pressure measurement. 
The trachea was cannulated and the ventilation of the animal was 
controlled with a Harvard Apparatus Rodent Respirator. Respiration was 
maintained at 60 breaths per minute. The tidal volume of 2-3 ml was adjusted 
for each animal according to the venti laUon gr<1pll <1ccompanying the resp-
irator·. 
A 3" X 5" piece of surgical drape was adhered to the abdomen. The 
surgical drape prevented loose hair clippings from getting on the exte-
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riori<;ed mesentery. I\ 2" midline incision, centered on the umbilicus, 
was made through the drape and into the peritoneal cavity along the linea 
alba. 
Each animal was placed on its right side in a holder on a specially 
0 
.. designed, constant temperature (37 C), water-heated, plexiglass microscope 
stage. Cotton-tipped swabs moistened with Tyrode's solution were used to 
gently remove a short length of ileum from the abdominal cavity. Once 
exteriorized, the mesentery was loosely draped over the viewing pedestal 
on the plexiglass stage. 0 A standing solution of warm (37 C) Tyrode's 
solution (compos'ition in m.M: NaCl 142.5; KCl 2.7; Cacl 2 1.4; HgC1 2 0.5; 
NaHC03 11.9; NaH 2Po4 0.3 .and glucose 5.5) adjusted to 300±5 mOsm with NaCl 
and to pH 7.4 with HCl and NaOH was used to keep the tissue moist. A small 
piece of polyvinyl film (Saran Wrap) was used to cover the mesentery to 
retard evaporation, yet permit observation. 
D. SELECTION OF VESSELS 
A section of the mesenteric microcirculation consisting of a 
vascular loop of an arteriole, capillaries and venules was selected for 
the measurement of red cell velocity. A schematic representation of such a 
loop is shown in Figure 1. The following criteria served to establish the 
normalcy of the microcirculation in each preparation: (1) flow through the 
terminal aiterioles was sufficiently rapid so that individual blood cells 
could not hc idcnti.ficd, (2) t.hc collccting venulcs hnd n stc;ndy, continuous 
fonvarcl flow w1thout evidence of retrograde flow or oscillntion, and (3) 
mean arterial perfusion pressure as measured in the left carotid artery was 
not l~ss thnn.70 mm Hg~ Thirty-fdur percent of tl1e animals were discarded 
because according to the criteria the_preparation was aberrant. 
FIGURE 1 
MESENTERIC HICROCIRCULi\TION 
This is a di.agr:1matic reprcscnt<1tion of the tenni.n<1l v:1scula-turc 
in the mesl'nteric ml.croci.rculntfon.· l.t consists of n vnsctt:l;lr. loop of 
an arteriole, capLLlaries and the effluent venule. Such vascular loops 
\vere. selected for the measurement of red c<:c:ll velocity. 
-22-
-23-
A number of changes occurred in the vasculature which indicated 
tissue deterioration and were used as criteria for terminating experiments. 
The changes generally occurred in the following order: (1) the appear-
ance of leukocytes sticking to or rolling along the walls of t~e collecting 
venules, (2) extravasation of red cells either by diapedesis or petechial 
hemorrhage, and (3) extensive intravascular coagulation. 
E. HICROSCOPE.OPTICS 
The plexiglass stage which held the rat and the exteriorized 
mesentery was placed on the mechanical stage of'a Leitz Pa~phot microscope. 
A xenon lamp '(XBO 150W) was used to transilluminate the mesentery. A 
magnified image of the mesent~ric microvasculature was projected onto a 
viewing screen by a projection prism (6.3 X) and two Leitz objectives 
(UH 20/0.33). One of the objectives was used as a long working distance 
condenser and the second was used as a high, dry objective. The total 
magnification realized at the viewing screen was 237 X. 
F. MEASUREMENT OF VESSEL DIHENSIONS 
The image of a. Bausch and Lomb stage micrometer was projected onto 
the-viewing screen. The distance between the minor ~ivisions (10 microns) 
was drawn onto the viewing screen. This graticule was used to measure the 
outside diameter of all vessels from which velocity recordings were made. 
G. ~IEASUIU~HI\NT OF HED CELl. Vl~T.OCTTY 
1\ llllHI!flc;ttlon nf till• du;ll-:-di.L pholonll'trlc tvchnlqul' of \v;tyl;llld 
and Johnson [ 117] \vas used to measure reel cell velocity. The image of a 
microvessel wa.-s aligned perpendicular to two parallel slits in a viewing 
screen as shown in Figure 2. As the image of a red cell passed'in front 
FIGURE 2 
EXPERIMENTAL ARRANGEMENT 
FOR ON-LINE.ME/\SUREHENT OF 
RED CELL VELOCITY 
PHOTODIODES 
UPST·REAM 
DOWNSTREAM 
COR RELATOR 
DIVIDER 
VELOCITY (mm/sec) 
TO RECORDER 
A t 
Schematic diagram of preparation and 'on-line red blood cell velocity 
mcnsuring syst~rn. Tmngc of microvcsscl Js projected onto n screen 
containing dual sllts. llpstrc;un ;mrl downstrcnm phobHI lod(:S <Jrc time 
correlated and the resulting ·time interval is divided into tl1e distance 
betwee~ the slits to obtain red cell velocities. 
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of the slits, the voltage output ~f a photodiode (United Detector Technology, 
Inc., PIN 020A) mounted behind each slit varied. When the vessel image 
was properly aligned, the magnitude of this variation was identical for 
both detectors, differing only iri the time it took for the image of the 
red cell to travel the distance between the two slits. This ttansit time 
was determined by an on-line cross-correlation technique [46, 118]. An 
analog divider circuit, programmed with the distance between the photo-
detectors computed th~ red cell velocity. 
A strip chart recorder (Offner Type R dynograph) was used to record 
contiriuously the red cell velocity ahd arterial pressure. Red cell velocity 
data was collected and tabulated at two or five second intervals over the 
observation period: These were used to calculate the average red cell 
velocity in the vessel. 
H. STATISTICAL ANALYSIS 
Homogeneity of varianr:.e was tested for by the F-maximum test [97]. 
Or:te w~y analysis of variance was used to analyze for significant differences 
between corresponding variables of the three experimental groups (control, 
shor·t-term and long-term streptozotocin-diabetics). The Scheffe contrast 
was used to determine which groups differed. Correlation coefficients 
were calulated according to .the methods of Pearson's (r) [23]. The 5% 
level of significance was used. 
CHAPTER IV 
RESULTS 
A. CONFIRMATION OF DIABETES MELLITUS 
The plasma glucose·concentrations and body weights of the control, 
short-term and long-term streptozotocin-treated animals are shown in Table I. 
At the time of streptozotocin injection the fed weight of t~e 59 treated 
animals was 329 ,± .4.8 grams. All values are means ± standard errors. Those 
animals used one week after the streptozotocin injection weighed 276 ± 9 
grams. This was an average weight loss of 53 grams. There was a more 
gradual weight loss· during subsequent weeks. The treated animals weighed 
an average of 266 ± 8.6 grams 25 days after the streptozotocin injection. 
In addition to the weight loss, the streptozotocin-treated animals 
exhibited polydipsia, polyphagia and polyuria. This is consistent with an 
induced diabetic state and was confirmed by the elevated plasma glucose levels 
in these animals. The plasma glucose concentrations of the non-treated 
animals was 82 ± 7 mg/dl. At the end of one week of diabetes mellitus, the 
plasma glucose concentration was 273 ± 30 mg/dl. As the duration of diabetes 
increased, this rose to 296 ± 36 mg/dl in the long-term diabetic animals. 
B. EFFECT OF STREPTOZOTOCIN DIABETES ON RED CELL VELOCITY 
The red cell velocity in the various comportments of the micro-
circulation is shown in Figure 3. This figure represents data from vioble 
mesenteric prcpilrntions of seven control (C), nine short-term (S) ;mel 
seven long-term (L) diabetic animals. 
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TABLE I 
PLAS~~ GLUCOSE. CONCENTRATIONS IN 
CONTROL AND STREPTOZOTOCIN-TREATED ANI~LS 
STREPTOZOTOCIN-TREATED 
CONTROL SHORT-TERM LONG-TERM 
" NUMBER OF ANI_HALS (N) 15 12 12 
AGE (days) 96 89 105 
±3 ±2 ±3 
WEIGHT (grams) 353 276 266 
±11.4 ±9 ±8.6 
DURATION OF DIABETES (days) 0 7 25 
±0.5 ±3 
PLASHA GLUCOSE (mg/ dl) 82 273 296 
±7 ±30 ±36 
The 24 streptozotocin-treated animals are those animals which 
survived the diabetes which developed following the injection of 
streptozotocin. The duration of diabetes refers to the time since the 
streptozotocin injection. 
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FIGURE 3 
EFFECT OF STREPTOZOTOCIN DIABETES ON 
RED CELL VELOCITY 
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ARTERIOLES CAPILLARIES VENULES 
Red cell velocity (m~an ± SEM) in art~rioles, capillaries and 
venules of 7 con·trol (C), 9 short-term (S) and 7 long-term (L) diabetic 
animals. The n is the number of vessels bbserved. The level of 
significance is indicated by the P values; ns indicates P > 0.05. 
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No statistically significant difference was found betHeen -the red 
cell velocities measured in the various microvessels of the control and 
short-term diabetic animals. The average red cell velocity in the 14 
control arterioles studied was 0.60 ± 0.10 mm/sec as compared with 0.68 ± 
0.12 mm/sec in the 24 short-term diabetic arterioles. ·In the 18 control 
capillaries, the red cell velocity was 0.45 ± 0.09 mm/sec versus 0.24 ± 
0.03 mm/sec in the 22 short-term diabetic capillaries. The velocity at 
which red cells moved through the 12 non-diabetic venules was 0.34 ± 0.07 
mm/sec. It averaged 0.30 ± 0.07 mm/sec in the 21 short-term diabetic 
venules. 
The red_cell velocity of the 20 arterioles studied in the long-
term animals \vas 1. 22 ±. 0.15 mm/ sec as compared with 0. 68. ± 0.12 mm/ sec 
for the short-term diabetic animals and with 0.60 ± 0.10 mm/sec for the 
control animals. The red cell velocity in the arterioles of the long-term 
diabetic group was signif~cantly greater (P < 0.025) than in the short-
term diabetic or control animals. 
The red cell velocity in the 20 capillaries studied in the long-
term di'al;>etic animals was 0.59 ± 0.12 mm/sec as compared with 0.45 ± 0.09 
mm/sec for the control animals and with 0.24 ± 0.03 miD./sec for the· short-
term diabetic animals.. The red cell· velocity in the capillaries of the 
long-term diabetic animals was significantly greater (P < 0.025) than in 
the short-term diabetic animals, but was not significantly_greater than 
in the control animals. 
The red cell velocity ln the 22 venulcs studied in the long-term 
diab.etic animals was 0._70 ± 0.08 mm/sec as compared with 0.34 ± 0.07 mm/sec 
for the control animals and 0.30 ± 0.04 mm/sec for the short-term diabetic 
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animals. The red cell velocity in the venules of the long-term diabetic 
animals was significantly greater than in the control animals (P < 0.005). 
or the short-term diabetic animals (P < 0.001). 
An average for the red cell velocity in each segment of the micro-
circulation was.determined for each preparation. The correlation between 
the severity of diabetes, as judged by the plasma gluc6se concentration, 
and the r~d cell velocity-in the arterioles, capilliries and venules ~as 
determined by calculating the Pearson (r) moment correlation coefficient. 
The correlation coefficients are shown in Table II. No significant 
correlation was found between the plasma glucose concentration and the red 
cell velocity in any segement of the microcirculation. 
C. EFFECT OF STREPTOZOTOCIN DIABETES ON VESSEL DIMENSIONS 
The caliber of the microvessels in the various compartments of the 
microcirculation of the same control (C), short-term (S) and long-term (L) 
animals is .shown in Figure 4. This represents data from the. same arterioles, 
capillaries and venules in which the red cell velocity was measured. The 
outside diameter of the arterioles in the control (C), short-term (S) and 
long-term (L) diabetic animals.was 12.5 ± 0.8 microns, 15.2 ± 1;4 microns, 
and 12.1 ± 0.8 microns, respectively. Tl1ese measurements were not significantly 
diEferent. The diameter of the capillaries in these animals was 7;9 ± 
0.4 microns, 7.7 ± 0.4 microns and 7.7 ± 0.5 microns, respectively. These 
measurements did not differ significantly. The caliber of the venules in 
the same control (C), short-term (S) and long-term (L) diabetic animals 
was found to be 22.8 ± 2.1 microns, 17.9 t 1.8 microns and 17.5 ± 1.4 
microns, respectiveli. Again, there was no statistical differenc~ •among 
these groups. 
TABLE II 
CORRELATION BET~ffiEN PLASMA GLUCOSE CONCENTRATION 
AND RED'CELL VELOCITY 
ARTERIOLES CAPILLARIES VENULES 
CORRELATION COEFFICIENT (r) 0.29 -0.07 0.08 
DEGREES OF FREEDOM (df) 18 17 17 
LEVEL OF SIGNIFICANCE p > 0.10 p > 0.10 p > 0.10 
This table shows the Pearson (r) moment correlation coefficient 
between the plasma glucose concentration and the red cell velocity in 
the arterioles, capillaries and venules of the non-diabetic and diabetic 
animals. The degrees of freedom arid the level ~f significance are also 
ii).dicated. 
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FIGURE'4 
EFFECT OF STREPTOZOTOCIN DIABETES ON 
VESSEL DIMENSIONS 
Outside clLnncter (nwnn L Sl\N) L'f <lrteriolc's, cnplll:Jries :mel 
venules of 7 control (C), 9 shnrl-tl'nn (S) nnd 7 IOnp,-term (L) di:1hctlc 
animals. The n is the number of vessels observed. The level of ' 
significance is indicated by the P values; ns indicates P > 0.05. 
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D. EFFECT OF STREPTOZOTOCIN DIABETES ON SYSTEHIC BLOOD PRESSURE 
Simultaneous with the measurement of red cell velocity in the 
various microvascular segmerits was the recording of blood pressure in the 
left carotid artery. The average mean blood pressure was calculated for 
the period of red cell velocity measurement. These data are shown in 
Figure 5. 
When the red cell velocity was being measured in the arterioles 
of the control (C), short-term (S) and long-term (L) diabetic animals, the 
blood pressure in the left carotid artery was 150 ± 4 mm Hg, 134 ± 4 mm Hg 
and -137 ± 3 mm Hg, respectively. There was a significant difference 
(P < 0.025) between the blood pressure in the control (C) and short-term 
(S) diabetic animal~ when arteriolar red cell velocities were being measured. 
No other differences were found. 
When the red cell velocity was being measured in the capillaries, 
the blood pressure was 146 ± 5 mm Hg in the control (C) animals as compared 
with .141 ± 3, mm Hg in the short-term (S) diabetic animals and 133 ± 3 mm Hg 
in the long-term (L), diabetic animals. · The only significant difference 
(P < 0.05) ~as found between the control and lorig-term animals. 
The blood pressure in the control (C), short-term (S) and 'long-t~rm 
(L) diabetic animals was 146 ± 6 mm Hg, 139 ± 3 mm Hg and 131 ± 3 mm .Hg, 
respectively, when the red cell velocity was being measured in the venules. 
There was no significant difference between'these values. 
From the cl;Jta presented in Figure 5, it appl'ars as :if there is· a 
trend for blsod pressure to decrease as the duration of diabetes lengthens. 
An average mean blood pressure was. determined for each preparation. Computation 
of the Pearson (r) correlation coefficient (r = -0.29; df = 21) for these 
data indicates no significant relationship exists between the duration of 
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EFFECT OF STREPTOZOTOCIN DIABETES ON 
SYSTEMIC BLOOD PRESSURE 
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ARTERIOLES CAPILLARIES VENULES 
Mean systemic blood pressare (mean ± Sml) in the left carotid 
artery oe 7. control· (C), 9 short:-term (S) and 7 long-term (L) diabetic 
animals measured at the same time red cell velocities were being recorded. 
The n is the number of vessels observed. The level of significance is 
indicated by the P values; ns indicates P > 0.05. 
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diabetes and systemic blood pressure. The correlation between systemic 
blood pressure and plasma glucose concentration (r = -0.15; df = 19) 
indicates that the apparent tendency for blood pressure to decrease as the 
duration of diabetes incieased is not related to the plasma glucose 
concentrations. 
E. EFFECT OF STREPTOZOTOCIN DIABETES ON LYMPHATIC ACTIVITY 
In the course of an experiment, a lymphatic vessel would occasionally 
. come into view. Hhen .this happened, the rates of contraction were measured. 
The relaxed and contracted diameters of the lymphatic vessels were also 
measured. These data are shown in Table III. 
Lymphatic vessels were seen in only two non-diabetic (C) animals. 
This was because the mesenteric fat pads hid them from view. When the 
mesenteric fat pads atrophied, the lymphatic vessels were exposed. Seven 
lymphatics wer.e seen in four short-term (S) and six lymphatics were seen 
in four long-term (L) diabetic animals. 
The contraction-relaxation cycles appear most rapid in the larger 
collecting channels (L50-250 microns). The periodicity varied from 7-33/min. 
TABLE III 
LYHPHATIC ACTIVITY 
IN NON~DIABETIC AND. STREPTOZOTOCIN DIABETIC RATS 
DIAHETER (microns) CONTRACTIONS 
GROUP RELAXED CONTRACTED PER MINUTE 
c 175 100 28 
c 130 110 18 
s 250 0 
s 150 0 
225 0 
s 120 90 24 
140 110 22 
210 130 . 7 
s 75 50 23 
L 150 120 9 
200 175 . 12 
L 250 200 10 
L 200 150 24 
200 150 33 
L . 150 125 14 
This table shows the relaxed and contracted diameters of collecting 
lymphatics in 2 control (C), 4 short-term (S) and 4 long-term (L) 
diabetic animals, along with .their corresponding rate of contraction. 
In ~wo of the short-term animals, the lymphafics showed no spontaneous 
contractions, hence {t is not known whether the diameter measured 
represents a relaxed or contracted diamet.er. 
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CHAPTER V 
DISCUSSIO~ 
A. INDUCTION OF DIABETES MELLITUS AND EVALUATION OF THE DIABETIC STATE 
The purpose of this study was to quantitatively examine the effects 
of diabetes mellitus on circulatory dynamics within a microvascular network. 
This was achieved by measuring the red cell velocity in the mesenteric 
microcirculation of an animal model of diabetes mellitus. 
Currently, streptozotocin is the drug of choice for the induction-
of experimental diabetes in laboratory animals [3, 49, SO]. The streptozo-
tocin treated animals exhibited a weight 1oss when compared with age-
matched controls. In addition, they exhibited polyphagia, polydipsiai 
and polyuria. This is consistent with an induced state of diabetes mellitus. 
The diabetic state was confirmed by the elevat,ed plasma glucose 
levels in these animals. The plasma glucose concentration in the short-
term diabetic animals was 273 ± 30 mg/dl and was 296 ± 36 mg/dl in the long-
term diabetic group, as compared with only 82 ± 7 ~g/dl in the non-treated 
control group. These values are in agre~ment with values reported in the 
literature [3, 49, SO] for glucose levels in rats treated with comparable 
doses of streptozotocin and after similar periods of time had elapsed. 
B. HICROC:IRCULJ\TION lN TilE INTESTINAL ~!ESENTI·:RY 
llnJikc structures, such ns skeletal. muscle, \vhich rcqui ~;e consldt'rnhl<' 
handling, the inter.ti.nc can be e;<;posed for study \vi th a mlnimum of hand] ing. 
The mesentery provides in a two-dimensional array all the elements of the 
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terminal vascular ~ed. It provides clear visualization of the vessel wall 
and blood cellular elements.· The thinness and vascularity of the mesentery 
make it a valuable structure for transillumination. This makes it possible 
to use a dual-slit photometric system for measuring red cell velocity [117]. 
The ubiquitous occurence of diabetic microangiopathy throughout 
the body makes it unlikely that an extravascular metabolic influence 
unique to a single organ is responsible for-the accumulation of PAS-positive 
material in the vessel_walls of arterioles, capillari~s and venules. This 
suggests that an intravascular derangement may be responsible for the 
development of microangiopathic lesions. 
The metabolic'influence of the loose connective tissue in the 
mesentery on the autoregulatory behavior of the terminal vascular bed is 
minimal. Flow through the mesenteric microcirculation is strongly regulated 
by myogenic mechanisms [48]. The mesenteric microcirculation is tailor 
made for investigating the influence of diabetes mellitus on microcirculatory 
phenomena. The results obtained would not be distorted by ~hanges in the 
metabolic environment of the vascular bed peculiar to the influence of 
diabetes mellitus on a parenchymatous organ. 
The most striking thing about the appearance of the diabetic 
m~sentery was the mark~d atrophy of the mesenteric fat cells. The decrease 
in the size of the fat cells is consistent \vith the increased mobilization 
of fatty acids in diabetes mellitus. [122]. The fat cells were very prominent 
in the non-diabetic animals. The microvessels were clearly visible only in 
a narrow zone along the margin of the fat pads. Larger arterioles and venules 
cbuld be less clearly discerned.through the overlying translu~ent adipocytes. 
In the diabetic animals it was as if the adipocyte quilt had been thrown 
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back, clearly exposing the complete distribtltion and branching pattern 
of the microvessels lying in the mesenteric bed. The vessels brought to 
view wer.e probably already in existence· at the time diabetes was induced 
'[98]. No gross anatomical differences in the appearance of the mesenteric 
microvascular architecture were observed. 
The preparations used in this series of experiments were physio-
logically sound. The flow in all the arterioles was sufficiently rapid 
so that individual blood cells could not be identified. Changes of red 
cell velocity in the capillaries .were irregular and unpredictable. The 
capillaries studied were all of the steady type in which individual red 
cell velDcity measurements fluctuated randomly around a stable mean. Changes 
in the direction of. movement, as well as in the number of capillaries with 
an active circulation were seen. The effluent flow by way of the post-
capillary venules had a steady continuous forward movement with no evidence 
of retrograde oscillation. 
Eiperiments conducted on control animals were interspersed with 
those conducted on diabetic animals. The microvessels studied in all the 
animals were taken from the same general area of the mesentery. The same 
criteria for assessing the initial viability of the preparations and the 
degree of deterioration were used id all the experiments. It is unlikely 
that bias in the selection of vessels or differences in the viability of 
the preparntions are responsible for the dLfforences observed in reel cell 
velocity. 
C. INFLUENCE OF STREPTOZOTOCIN ON RED CELL VELOCITY 
The.red cell velocity constitutbs a good index of blood flow velocity 
which faithfully ieflects all n~tural or induced changes of flow as shown 
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in the studies of 'A)ayland and Johnson [117] and Intagl:letta et. al. [46]. 
The red cell velocity in the arterioles, capillaries ~nd venules of the 
control animals (Figure 3) \vas 0.60 ± 0.10 mm/sec, O.Lf5 :!: 0.09 mm/sec and 
0.34 ± 0.07 mm/sec, respectively. These results are comparable to those 
reported in the literature [10, 46, 83, 84] and with previous results 
obtained in this laboratory (unpublished observations). 
The short-terre diabetic animals served as hyperglycemic controls. 
Blood sugar levels per se have been demonstrated to have no effect on blood 
rheology [13]. Therefore, no difference in red ce11 v~locity was expected 
to be found between the control and short-term diabetic animals. As antici-
pated, there was no significant difference between the red cell velocity 
measured in the microcirculation of the control animals and the red cell 
velocity measured in the arterioles (0.68 ± 0.12 mm/sec), capillaries 
(0.24 ± 0.03 mm/sec) and venules (0.30 ± 0.04 mm/sec) of the short,..-term 
diabetic animals: 
The red cell velocity in all segments of the microcirculation of 
the long-term diabetic animals was greater than that measured in either 
the control or the short-term diabetic animals. The red cell velocity 
in the arterioles (1.22 ± 0.15 mm/sec) was more than twice that of the 
control anim~ls and 1.8 times greater than that of the short-term diabetic 
animals. In the capillaries of the long-term diabetic animals, the red 
cell velocity (0.60 :1: 0.12. mm/scc) was 1.3 times th:1t of the non-diabetic 
ailinnls and 2. 5 t imcs that o( the short-term diabetic antmals. Slmilar 
incteases of red cell velocity were seen in the venular segment. The red 
ce-ll velocity in this segment of the microvascualture was 0.70 ± 0.08 mm/sec 
in the long-term diabetic ariimals. This was·more than double the red cell 
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velocity in the vessels of the non-diabetic animals and 2.4 times that 
of the short-term diabetic animals. 
Since an increased red cell velocity was observed in the mesentery 
after one ·month of diabetes, it is a log-ical assumption tha·t this happens 
in other vascular beds as well. More importantly, the changes in red cell 
velocity took place before thickening of capillarybasement membranes has 
been reported to occur in chronically streptozotocin diabetic rats [12]. 
The increased red ~ell velocity observed in this study also is 
consistent \vith ·the l,lyperemic conditions observed in various tissues of · 
diabeti~ patients [2, 11, 18, 36, 38, 40, 55]. Blood flow to an organ can 
be increased by only three mechanisms. These are: (1) an increase in 
blood pressure, (2)' an increase in the cross-sectional area of the resistence 
vessels, and (3) a decrease in viscosity. As these variables were not 
measured in the.diabetic patients, it is not possible to define clearly 
the mechanism responsible for their elevated flow. 
D. SUGGESTED HECHANISMS FOR THE INCREASED RED CELL VELOCITY FOUND IN 
STREPTOZOTOCIN RATS 
Becau~e the blood pressure of the long-term diabetic animals was 
not greater than that of the control or short-term diabetic animals, the 
increased red cell velocity found in the long-term diabetic rats cannot 
be explained on the basis of this parameter. In order to account for the 
increased reel cell. vcloci ty on the basis of' Vl'ssel dimensions alone, the 
IHL'<IStll"l'd d Llmt'Lt•rs 1mul.d have to Ill' 'i lt1 B micron~; .I aq~ct·. ( 1 ·:q tl<l u 0 11 ,, • 7 
on page 136 of Charm and Kurland [14] was used to make this calculation.) 
In none of the microvascular segments did the outside diameter differ 
sign'ificantly from group to group. An increase of the inside radius of the 
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blood vessel net reflected in a larger outside di~meter could account for 
a portion of the increased red cell velocity in the long-term diabetic 
group. The magnitude of the diameter change required and the thickness 
of the vessel walls'at.this level of the microcirculation makes this 
unlikely. 
A decrease in viscosity to half of normal values would result in 
a: doubling of blood flow. In vitro rheological studies of blood an.d serum 
have demonstrated that the viscosity of blood and serum i"s elevated in 
diabetics with evidence of micr6angiopathy [19, 45, 67, 69, 70, 95], and 
more so at low shear rates [45]. There has been one report of decreased 
serum viscosity in a group of diabetic patients [75]. Although the Ostwald 
viscometer 'employed-by Mosora et. al. [75] appears to be a simple device, 
its use is subject to a number of errors [15] that make it inappropriate 
for quantitative biorheological measurements. This observation of decreased 
serum viscosity must be discounted until a more detailed report is published 
clearly defining the metabolic condit~on of the patients and the,presence 
or absence of microangiopath~. 
The relationship between the viscosity and the shear rate of blood 
is such that viscosity.increases as the shear rate is reduced towards zero 
(shear thinQing) and viscosity at high shear rates is essentially independent 
of shear [17}. A wide range of shear rates exist within the vascular 
compnrtmL'nts of the circul.:1t:lon. Tt ls ost: im;ll:c'd tliat tlw lowest ~;h<':lr 
rates arc to lw [otllid Jn the posl-caplllary vcnul.cs ['!6, WJ]. lf the shear-
dependent region is encountered in the V<'ntd.es, then the viscosity of 
blood would be preferentially elevated in this vascular compartment. The 
expected response in the venules to a shear-dependent increase in viscositv 
' " 
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would be sluggish flow. Such a response in tl1e post-capillary venules 
would be even more pronounced if the degree of siiear-dependence of blood 
viscosity is enhanced [45]. 
As blood traverses the microcitculation it does not flow as a 
homogeneous suspension as it does in larger vessels; rather, it flows as-
a two phase system--cells and plasma. Plasma alone is the liquid phase 
and plasma viscosity is ~he significant viscosity parameter. Blood vi~cosity, 
per se, is of little importance when considering microcirculatory flmv-
[14, 47]. Chien [17) has developed a theory of blood viscosity that is 
especially applicable to the microvasculature where flow is of two distinct 
phases (cells and plasma) rather than bulk flow is taking place. This 
theory of blood viscosity is based on the concept of effective cell volume, 
which is defined as the sum of the cell volume-and the volume of the 
surrounding fluid that behaves as if it were a rigid. extension of the cell. 
Red cell velocity exceeds plasma velocity in blood flow through 
small diameter vessels [106]. The difference between the velocity of plasma 
and the velocity of red cells. is accentuated by inc~eases of blood [85] 
or plasma [86] viscosity. Rosenblum [85, 86] observed that when the 
fluorescein transit time through the cerebral microcirculation ~f mice 
was lengthened because of increased plasma viscosity, erythrocyte velocity 
measured by ultra-high microcinematography was within normal limits or 
elevated. Rosenblum's results are consistent ;v-ith Chien's theory of blood 
rheology [17]. According to the concept of effective cell volume, an increase 
in plasma viscosity would increase cell deformation and therehy decrease 
the e~fective cell volume. This would result in a decrease in the relative 
apparent viscosity of blood. An increase in red cell velocity would resnlt. 
It is possi~Jlc that a shear-clcpcnclent increase -In plasm<1 viscosity 
occurred in the long-term diabetic animals. The increased red cell velocity 
in the arterioles and venules of the long-term diabetic animals is con~istent 
with Rosenblum's observation of normal or elevated erythrocyte velocity in 
animals with an elevated plasma viscosity. Valid conclusions ab~ut plasma 
viscosity, the influence of plasma viscosity on red cell deformation and 
red cell velocity cannot be reached by measuring red cell velocity alone. 
An in vitro assessment of the viscosity of plasma withdrawn from animals 
in which the red cell velocity has be~n measured is necessary in order to 
r~ach such conclusions. 
The red cell velocity in the venules of 3 of the 9 short-term 
diabetic animals was less than 60% of the group mean (0.30 ± 0.04 mm/sec). 
In only one of these animals was. intravascular eiythrocyte aggregation 
observed when the preparation was still considered viable. The a'ggregates 
were observed only in the venular segment of the microcirculation. They 
were small, consisting of only ~hree or four cells clumped together. They 
did not distort or plug the vessel. Aggregation not related to preparation 
deterioration was observed in only one other short-term diabetic animal. 
The red cell aggregates were distinctly visible in the venular segment. 
They did not distort or plug the venules. The velocity of the red cells 
in the venules of this preparation averaged 0.38 rnrn/sec, slightly faster 
than the average velocity for this group. 
Nn ar,gn•g:1Llons or red cc.lls not :1ttrJhutabl.e to pr<'p;n·atlon 
deterioration wc="re observed in the microcirculation of tl1e long-term dl.abetic 
anim'als. This may be due to the disa.ggregating shear forces of the· blood 
flmv being greater than the adhesive forces acting between red cells. 
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Therefore aggreg-ates were never formed. It may also be that· aggregates 
were formed, but because of their velocity and the flicker-fusion 
characteristics·of the human eye, they were not distinctly visible. Use 
of an optical recording system with sufficient resolution that permits 
review of the observations is necessary in order to adequately determine 
the extent of red cell aggreg~tion under conditions of increased red cell 
velocity in these animals. 
In the post-capillary venules with diameters slightly larger than 
the major diameter of red blood cells, red cell aggregation can only .he in 
the form of linear rouleaux with its axis aligned with flow. Under such a 
geometric limitation, the theory of blood flow presented by Chien [17] 
predicts a reductiori in effective cell volume and a decrease in the apparent 
viscosity of bl6od. If aggregates did form in the post-capillary Venules, 
the expected response would be an increase in velocity. The elevated red 
ve.loc_ity measured in the post-capillary venules of the long-term diabetic 
animals is consistent with this micro-rheological theor'y of Chien. 
Both increased plasma viscosity and enhanced intravagcular aggre-
gation l1ave been related to chang~s in plasma protein composition [27, 68, 
69]. There is a decline in the plasma concentration of albumin and a 
concomitant increase in that of a-glycoproteins. These proteins are produced 
by liver p~renchymal cells. Thus a change in the liver protein synthesis 
pattern appears important in the development of diabetic microangiopathy. 
The clcgrcl' of dlabctes rcquired.to disrupt liver mctabol.Lsrh is not knm.,rn [69]. 
It may be that the diabetes mellitus in the animals used in these experiments 
was not severe enough and/ or of long enough duration to result in 'the 
disruption of liver metabolism and produce these changes in plasma proteins. 
I 
Stteptozotocin has been used to produce diabetes mellitus of 
graded severity in laborator~ animals [49, 50]. A streptozotocin diabetic 
animal can be used to analyze the relationship between depleted pancreatic 
immunoreactive insulin, alterations in liver protein synthesis patterns 
and deranged carbohydrate me·tabolism. Such an animal model would give 
information about the duration and severity of diabetes necessary to disrupt 
·~ liver metabolism. This animal model would give information about the degree 
of diabetes necessary to produce changes in the rheological properties of 
blood and plasma. An in vitro assessment of blood and plasma viscosity 
could be made and compared with alteration~ in the composition of the 
plasma proteins. 
The fluid ~echanical processes which occur during the movement of 
an erythrocyte through the lumen of a capillary are very complex. They 
include the interaction of a deformable red ceil with the luminal surface 
of the capillary wall. The nature of the endothelial layer and its possible 
effects on the determination of microcirculatory flow dynamics have not 
been determined [37]. 
The blood in the microcirculation is not in direct contact with 
the endothelial cells, but rather with the layer or film adherent to them. 
Luft [117] has electron micrographic ~vidence for the existence of a layer 
lining the lumen of blood vessels. Copley and others [20, 22, 77, 109] 
have postulated the endo-endothelial linin)S of b.lood vessels consists of a 
fibrin film \vld ch is clynamlcally 111~1i.nt<Ji ned and con trolled hy fibrinolytic 
processes in the marginal plasm·a layer. 
It h<ls been observed that tubes coated with fibrin offer less 
resistance to blood and plasma flowthan uncoated tubes [20]. The physical 
mechanism responsible for the·decreased resistance to blood flow in fibrin 
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coated tubes is not known [ 37]. 0n~ possibility is the effect of the 
electric ~barge on the red cell and vessel wall. Most cells are negatively 
charged and the negatively charged tubing affords lower flow resistance to 
red cells [15]. Oka has ~uggested that the apparent viscosity of blood 
and pJasma will always show a decrease when blood is in contact with 
negativ~ly charged substances [77]. 
Electrokinetic phenomena arise when movement occurs along the. 
solid/liquid interface of a charged system [90, 91]. This condition is 
duplicated in the blood vessels of all living animals .. The role of· electrical 
forces in the vascular system has not· been readily accepted exc'ept for 
potentials measured in connection with contraction of the he~rt and of 
vascular smooth mu~cle. _The hemodynamics of the vascular system have over-
shadowed the electrical properties of the surfaces of blood cells and of 
the endothelial lining of blood vessels. The in vivo and in vitro data 
relative to the negative charge on the components of the vascular system 
suggest that electrokinetic phenomena are significant ~.,rheri. flow in. the 
microcirc~lation is being considered ·[15, 41, 87]. Alterations in the 
charge carried by any of the components of the vascular system may be of 
significance as regards the interactions which occur between components 
of the system. 
There is no reason to believe that reactions which alter the base-
ment meniliranc will not ltave a compatable adtion on the layer lining the 
lumen of blood vessels. The usc of ruthenium red to stain the cndo-
endothelial layer would show whether the fine structure of this l<tyer 
is altered in diabetes [21, 61]. The importance of changes in the erido-
endothelial layer for microcirculatory hemodynamics co~ld be obtained from 
r 
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cross-perfusion studi~s. A segment of intestine and mesentery could be 
-isolated from a streptozotocin-diabetic animal and perfused with blood 
from a non-di.abetic animal. The red cell velocity could be measured in 
such a preparation, 
It is conceivable that a change in the electrical characteristics 
of the vessel wall could influence transcapillary fluid exchange via 
electro-osmotic processes. Such changes ~ould also result in the collection 
of fibrin at the luminal surface of the endothelium. The net effect would 
b~ the increased deposition of fibrin and other plasma proteins in the 
walls of the blood vessels. These fibrinous deposits, being remot~ from 
fibrinolytic processes in the vessel wall, undergo ageing changes and 
eventually come to.stain as collagen [59, 60]. It is interesting to note 
that on the basis of its amino acid composition, Spiro [105] has suggested 
that the basement membrane belongs to the collagen family of proteins. 
The thickening of the basement membrane that occurs in diabetes 
is not continuous along the entire capillary b~t is segmental in nature 
[53, 124]. If the excessive accumulations of basement membrane material 
were the ~onsequence of a generalized disorder in productiori or removal~ 
a more uniform thickening would be anticipated. The patchy and irregular 
thickening is more consistent with localized filtration and deposition. 
The relation~hip of the basement membrane thickening to the increased 
dinmetcr of the intr-ncellular cleft in diat;ctes [113] requires more study. 
f{egional variatlons in muscle capll L[1ry b;u;.emcnt membrane thickness 
have he-en reported 1n normaL subjects [92, J 15, 125, L26]. Electron 
~icroscopic studies of diabetic capillaries have demonstrated that the 
basement membrane of most, if not all, tissues is thickened, although 
r 
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perhaps not to the same extent [92, 125]. ( Electron microscopic examina-
tion of th~ capillary basement membrane in the glomerulus~ retina and 
skeletal muscle of chronically streptozotocin-diabetic rats has shown 
that the basement membrane thickens at different rates in these tissues 
[12]. In addition to'longitudinal permeability gradients [128], there 
are regional differences in capi1lary permeability [ 42, 64, 108]. It 
would be wprth irivestigating the relationship between the regional 
differences in capillary ~ermeability and the thickness of the capillary 
basement membiane. If the function of the capillary basement membr~ne 
is eventually defined, this information would be one of the important 
pieces of the puzzle. 
As a result of the interaction between hydrostatic and colloid 
osmotic pressures, the amount of fluid leaving the microcirculation 
rqdial to the blood flow is of the order of 0.1% of the local blood flow 
[47]. In the glomerular capillary, the filtration fraction is of the 
order of 20% of the renal plasma flow. The glomerular capillary with 
the greatest filtration volume of any capillary in the body has a basement 
membrane 10 to 20 times thicker than that of any other capillary. In 
diabetes, not only does the basement membrane thicken, but the capillary 
permeability also increases. This suggests that the basement membrane 
may, in addition to its role as a molecul~r sieve, function as an osmotic 
imbiber of W;lter and COntribute to the tissue 011COtic pressure in the 
Starlit~g equation for tLmscapillary fluid ·exchange. • 
The 'physiologic role of the lymplwt ic system in m.'lintaining 
interstitial fluid volume has become more appreciated in recent years 
[42, 43, 45, 47]. Pertubations of the Starling paramefers that result 
r 
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in an incr~ased transcapillary filtration would cause an increase in the 
interstial fluid volume unless compensated for by adjustments in lymph 
flow. The increase in capillary permeability of diabetic patients 
suggests that lymphatic activity would have to be enhanced in order to 
maintain interstial fluid volume. 
Without injection of a 1-2% solution of Evan's blue dye in 
physiological saline, the lymphatic terminations do not show up against 
the translucent grtiund substance of the mesentery [129]. Collecting 
lymphatics are prominent. They are distinquished by the pr~sence of 
valve leaflets and show spontaneous contractions. 
Lymphatics were rarely seen in the mesentery of non-diabetic 
animals. They were obseured from view by the heavy deposits of fat in 
the mesentery. The same decrease in fat cell size that exposed the 
complete distribution and branching pattern of the termi.nal microvasculature 
also exposed the mesenteric lymphatics in the diabetic ani~als. 
On.Ly collecting lymphatics were seen in this series. of experiments. 
The contraction-relaxation cycles \ifere most rapid in the Luger collecting 
channels (150-250 microns). The periodicity of the contractions (7-33/min) 
' ' . 
cover a broader range than the 15-18 contractions per minute repoTted by 
Zweifach and Prather [129] for lymphatics of this size. The qualitative 
evidence accumulated in this study does not give any definitive anS\ifer 
concerning enhanced lymphatic activity in diabetic animals. 
CHAPTER VI 
SUMMARY 
The microvascular manifestations.of diabetes mellitus present 
. a serious clinical problem .for the diab'etic patient, far more so than 
do the derangements in carbohydrate metabolism. LJttle is knmm about 
the basic pathogenesis, of diabetic microangiopathy. Alterations in 
blood flow to various organs appear before pathological lesions. The 
purpose of this study was to qualitatively examine the effects of diabetes 
mellitus on circulatory dynamics within a microvascular netw6rk. This 
was achieved by m~asuring the red cell velocity in the mesenteric micro-
circulation of an animal mod~l of diabetes mellitus. 
The red cell velocity in the arterioles, capillaries and venules 
of the control animals was 0.60 ± 0.10 ~n/sec, 0.45 ± 0.09 mm/sec and 
0.34 ± 0.07 mm/sec, res·pectively. These results are comparable to those 
reported in the literature and with previous results obtained in this 
labdratory. The red cell velocity measured in the arterioles (0.68 ± 
0.12 mm/sec), capillaries (0.24 ± 0.03 mm/sec) and venules (0.30 ± 0.04 
* 
mm/ sec) of the short--term diabetic: animals do not differ significantly 
from ~ontrol values. The red cell veloci~y in all segments of the 
microcirculation of the long-term diabetic ::mimnls was gre.1ter th<tn 
that mc:Jsurcd .Ln t•lthcr the control or short-term dinbclic :m.lmrll s. For 
the long-term diabetic :mlmals the values for the red cell velocity i_n 
the arteriole's, capillaries and venules were 1.22 ±. 0.15 mm/sec, 0.59 ± 
0.12 mm/sec and 0.70 ± 0 .. 08 mm/sec, respectively. 
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The increase in red cell velocity in the long-term diabetic 
animals is not due .to an increase in blood pressure or outside diameter 
bf the blood vessels. The increased red cell velocity may be due to 
either an increase in the .inside radius to wall thickness ratio, a decrease 
in the effective cell volume due to moderate rouleaux formation and/or 
increased plasma viscosity, or a change in the interaction of red cells 
with the endo-endothelial lining of blood vessels such that re~istance 
to flow is lessened. 
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HETABOLIC INFORHATION 
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CONTROL ANIMALS 
Preparation Age of Duration Weight Plasma 
Number Rat of Diabetes Glucose 
(days) (days) (grams) (mg/dl) 
1 90 0 430 
2 85 0 53 
4 81 0 300 73 
. 7 82 0 330 99 
10 95 0 350 57 
11 97 0 400 
16 117 0 400 120 
19 81 0 290 108 
21 114 0 365. 109 
22 101 0 335 74 
23 101 0 332 
31 93 0 320 74 
32 97 0 330 60 
35 98 0 350 102 
37 110 0 410 60 
N 15 15 14 12 
Total 1442 0 4942 989 
He an 96.13 0 353 82.42 
Standard Deviation 11.43 0 42.47 23.70 
Variance 130.64 0 1803.70 561.69 
S.E.H. 2.95 0 11.35 6.84 
-64-
SHORT-TERH DIABETIC ANIHALS 
Preparation Age of Duration · Weight Pia.sma 
Number Rat of Diabetes Glucose 
(days) (days) (grams) (mg/dl) 
3 85 3 325 183 
5 m 7 310 211 
6 82 8 310 170 
12 97 7 300 
13 98 8 260 229 
18 81 8 250 
20 82 9 227 430 
24 82 7 300 24.0 
25 97 7 270 
26 98 8 260 332 
27 99 9 260 278 
28 84 9 246 384 
N 12 12 12 9 
Total 1066 90 3318 2457 
:t-iE~ an 88.83 7.5 276.5 273. 
Standard Deviation 8.01 1.62 31.11 90.87 
Variance 64.16 2. 62 967.83 8257.36 
S.E.H. 2.31 0.47 8.98 30.29 
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LONG-TERM DIABETIC ANIMALS 
Preparation Age of Duration Weight Plasma 
Number Rat of Diabetes Glucose 
(days) (days) (grams) (mg/dl) 
8 96 14 300 222 
9 95 21 240 147 
14 112 30 280 434 
15 117 35 280 409 
17 118 36 290 500 
29 90 14 250 269 
30 104 14 293 107 
33 97 21 230 292 
34 98 22 230 217 
36 111 23 280 419 
38 110 35 220 401 
39 112 37 300 346 
N 12 12 12 12 
Total 1262 302 3193 3556 
He an 105.17 25.17 266.08 296.33 
Standard Deviation 9.63 9.03 29.92 125.19 
Variance 92.74 81.54 895.21 15672.54 
.S.E.M. 2.78 2.61 8.64 36.14 
-6<1-
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APPENDIX.B 
DATA 
Red Cell Velocity 
Vessel Dimertsions 
Average Mean Systemic Pressure 
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' ' 
ARTERIOLES: CONTROL ANIMALS 
Preparation Red Cell Vessel Average Mean 
.Number Velocity Diameter Systemic Pressure 
(mm/sec) (microns) (mm/Hg) 
4 0.401" . 15 156 
0.478 15 157 
0.649 12 147 
0.244 18 130 
16 0.219 10 153 
19 0.51 10 160 
0.42 10 -145 
21 0.30 10 170 
0.27 15 160 
32 1. 47 15 150 
0. 55. 10 150 
1.10 15 150 
0.83 10 115 
o. 93· 10 165 
N 14 14 14 
He an 0.5979 12.5000 150.5710 
Standard Deviation 0.3660 2.8488 14.0697 
Variance 0.1340 8.1154 191.9560 
S.E.H. 0.0978 0.7614 3.7603 
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ARTERIOLES: SHORT-TERM DIABETIC ANIMALS 
Preparation Red Cell Vessel Average Hean 
Number Velocity Diameter Systemic Pressure 
(mm/sec) (microns) (mm/Hg) 
3 0.021 30 120 
0.049 25 107 
0.169 20 95 
5 1. 268 12 122 
6 0.884 12 120 
1.794 15 130 
0.695 10 120 
12 . o. 323 10 151 
0.514 9 127 
0.426 20 115 
0.'264 30 107 
13 0.893 25 135 
0.357 15 150 
20 0.45 12 150 
0.79 10 150 
2.34 10 156 
26 0.15 10 155 
0. 30 10 14.8 
27 0.43 14 145 
0.36. 12 150 
1. 39 22 147 
28 1.07 12 142 
0.53 9 141 
0.86 11 145 
N 24 2.4 24 
Mean 0.6800 15.2083 134.5000 
Standard Deviation 0.5664 6.6983 17.5774 
Variance 0.3208 44.8677 308.2610-
S.E.M. 0.1156 1. 36 7 3 3.5839 
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ARTERIOLES: LONG-TERH DIABETIC ANU!ALS 
Preparation Red C.ell Vessel Average Mean 
Number Velocity Diameter Systemic Pressure 
(mm/sec) (microns) (mm/Hg) 
14 0.387 18 100 
30 1. 08 10 144 
0.64 9 144 
1.99 10 144 
0.80 9 144 
0.41 10 144 
0.52 9 128 
33 2.66 10 144. 
1.06 10 115 
34 1.45 8 150 
2.45 15 148 
0.86 9 148 
36 0.81 9 135 
1. 57 18 ,135 
0.89 9 135 
1. 74 18 139 
2.16 18 120 
38 0.97 12 135 
39 0.83 "15 147 
1.12 15 148 
N 20 20 20 
He an 1.2200 12.0500 137.3500 
Standard Deviation 0.6702 3.7060 12.9097. 
Variance 0.4491 13.7342 166.6600 
S.E.N. 0.1499 0.8287 2.8867 
-}0-
CAPILLARIES: CONTROL ANIMALS 
Preparation Red Cell Vessel 'Average Mean 
Number Velocity Diameter Systemic Pressure 
(mm/ sec) (microns) (mm/Hg) 
1 0.26 .10 167 
4 0.136 7 138 
Q.084 7 113 
7 0.574 8 120 
1.288 8 .120 
0.708 5 95 
0. 677 8 133 
16 0.166 6 148 
0.293 . 7 153 
0.15 9 155 
19 0.15 10 160 
0.66 8 160 
0.23 8 160 
21 0.21 7 164 
0.23 7 164 
32 0.59 11 158 
0.46 5 160 
1. 21 11 155 
N 18 18 18 
He an 0.4489 7.8889 145.7220 
Standard Deviation 0.3589 1. 7786 21.0120 
Variance 0.1288 3.1634 4!11. 5060 
S.E.M. 0.0846 0.4192 4.9526 
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I! 
I 
CAPILLARIES: SHORT-TERH DIABETIC ANIMALS 
Preparation Red Cell Vessel Average Hean 
Number Velocity ·Diameter . Systemic Pressure 
(mm/ sec) (microns) (mm/Hg) 
3 0.091 10 117 
6 o. 239 6 112 
0.066 8 112 
12 0.395 7 150 
0.380 6 151 
0.520 10 151 
20 0.075 8 147 
0.25 9 157 
0.10 9 144 
'0.129 8 140 
o. 23 8 140 
0.27 8 150 
0.21 4 150 
26 0.35 7 150 
0.16 8 140 
0.12 10 137 
0.24 8 130 
27 0.10 5 150 
0.15 10 140 
28 0.55 6 141 
0.27 8 144 
0.38 6 145 
N 22 22 22 
He an o. 2404 7.6818 140.8180 
Standard Deviation 0.1400 1.6729 12.5911 
Variance 0.0196" 2.7987 158.5360 
S.E.H. 0.0299 0.3567 2.6844 
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CAPILLARIES: LONG-TERM DIABETIC ANIMALS 
Preparation Red Cell Vessel Average Mean 
Number Velocity Diameter Systemic, Pressure 
(mm/ sec) (microns) (mm/Hg) 
14 0.344 .8 135 
0.168 6 103 
0.104 ' 10 130 
0.086 8 128 
30 0.84 4 144 
0.53 10 144 
0.48 8 .144 
33 0.20 7 120 
0.37 5 115 
34 1. 7·5 5 140 
2.34 6 148 
0.42 5 146 
36 Q.47 10 133 
0.21 10 132 
0.26 10 137 
0.57 10. 139 
38 0.78 8 118 
0.94 8 142 
39 0.53 9 123 
0;45 7 130 
----
N 20 20 20 
He an o. 5920 7.7000 132~5500 
Standard Deviation 0.5570 2.0026 11.9229 
Variance 0.3102 4.0105 142.1550 
S.E.H. 0.1245 0.44.78 2.6660 
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VENULES: CONTROL ANIMALS 
Preparation Red Cell Vessel Average Hean 
Number Velocity Diameter Systemic Pressure 
(mm/ sec) (microns) (mm/Hg) 
1 0.075 15 164 
0.307 20 173 
4 0.055 30 123 
0.727 30 138 
0.129 35 133 
7 0.761 28 100 
16 0.390 15 143 
21 0.140 11 170 
0.190 20 170 
32 0;49 20 150 
0.28 25 145 
0.49 25 145 
N 12 12 12 
He an 0.3375 22.8333 146.1670 
Standard Deviation 0.2399 7.2216 21.5526 
Variance. 0.0575 52.1515 464.5150 
S.E.H. 0.0693 2.0847 6. 2217 
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VENULES: SHORT-TERM DIABETIC ANUIALS 
Preparation Red Cell Vessel Average Mean 
Number Velocity Diameter Systemic Pressure 
(rnrn/ sec) (microns) (mm/Hg) 
3 0.122 40 90 
6 0.031 25 135 
0.047 28 130 
0.267 9 120 
0.018 15 120 
12 0.349 17 151 
0.413 11 127 
13 0.599 35 140 
20 0.60 10 155 
0. 26 . 13 150 
0.45 1"5 150 
0.30 20 150 
0.38 12 150 
26 0.11 12 148 
0.19 8 148 
27 0.15 15 150 
0.23 14 150 
0.37 20 140 
28 0.61 18 140 
0.45 14 137 
0.'29 25 141 
N 21 21 21 
He an o. 2971 17.9048 139.1430 
Standard Deviation 0.1832 8.4552 15.2685 
Variance 0~0336 71.4904 233.1280 
S.E.H. 0.0400 1.8451 3.3319 
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VENULES: LONGrTERl1 DIABETIC ANIHALS 
Preparation Red Cell Vessel Average Mean 
Number Velocity Diameter ·systemic Pressure 
(mm/ sec) (microns) (mm/Hg) 
14 0.124 30 103 
30 0.69 20 144 
0.97 11 144 
0.69 15 140 
0.38 20 135 
33 0.94 12 115 
. 0.53 10 118 
0.96 18 100 
34' 0.48 16 150 
1. 37 10 148 
36 0.26 25 135 
o. 72 13 139 
0.49 13 129 
0.68 25 140 
0.48 25 111 
38 o. 72 12 122 
0.63 25 127 
1.48 10 135 
1.11 20 139 
1.08 13 140 
39 0.43 28 152 
0.17 15 124 
N 22 22 22 
Mean 0.6991 17.5455 131.364'0 
Standard Deviation 0~3606 6.3899 14.7440 
Variance 0.1300 40.8311 11.2238 
S.E.M. 0.0769 1. 3623 3.1434 
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APPENDIX C 
STATISTics· 
-77-
RED CELL VELOCITY 
ARTERIOLES: 
ANOVA 
Source of 
Variation 
Between Groups 
Within Groups 
Total 
SCHEFFE CONTRAST 
Control 
Short-tetm 
CAPILLARIES: 
ANOVA 
Source of 
Variation 
Between Groups 
Within Groups 
Total 
SCHEFFE·CONTRAST 
Control 
Short-term 
VENULES: 
AN OVA 
df Sum of 
Sguares 
2 4.3209 
55 17.6534 
---57 21.9743 
Short-term 
0.19 
df Sum of 
Sguares 
2 1.3163 
57. 8.4956 
59 9. 8119 
Short-term 
2.89 
Source of df Sum of 
Squares 
1.9922 
4.0344 
6.0266 
Variation 
Between Groups . 2 
Within Groups. 52 
Total 54 
He an F 
Sguares 
2.1605 6.7310 
0.3210 
Long-term 
9.93 
9.91 
Mean .F 
Sguares 
0.6581 4.4156 
0.1490 
Long-term 
1.30 
8.69 
Mean 
Sguares 
0.9961 
0. 0776 
F 
12.8386 
SCHEFFE CONTRAST ~~--------------------------Short-term 
Control 
Short-term 
0.16 
_:_78-
Long-term 
13.08 
22.38 
ARTERIOLES: 
ANOVA 
Source of df 
Variation 
Between Groups 2 
Within Groups -55 
Total 57 
SCHEFFE CONTRAST 
· Contro"l 
Short-term 
·cAPILLARIES: 
ANOVA 
Source of 
Variation 
Bet\..reen Groups_ 
Within Groups 
Total 
SCHEFFE CONTRAST 
Control 
Short-term 
VENULES: 
ANOVA 
Source of 
Variation 
Between Groups 
Within Groups 
-
Total 
df 
2 
57 
59 
df 
2 
52 
54 
DIAHETER 
Sum of 
Squares 
126.0230 
1398.4100 
1524.4330 
Short-term 
2.55 
Sum of 
Squares 
0.4990 
188.7500 
189.2490 
Short-term 
0.13 
Sum of 
Squares 
246.5980 
2860.9300 
3107.5300 
He an 
Squares 
63.0117 
F 
2.4783 
Long-term 
0.08 
4.28 
He an 
Squares 
F 
0.2495 0.0753 
3. 3114 
Long-term 
0.11 
0.001 
He an F 
Squares 
123.2990 2.2411 
55.0178 
-'~CHEFFE CONT~V\ST --,---~-------------,­
Short-term 
Control 
Short-term 
3. 71 
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Long-term 
1.09 
3.95 
AVERAGE MEAN SYSTEMIC PRESSURE 
ARTERIOLES: 
ANOVA 
Source of df 
Variation 
Qetween Groups 2 
Within Groups 55 
Total 57 
SCHEFFE CONTRAST 
control· 
Short-term 
CAPILLARIES: 
ANOVA 
Source of 
Variation 
Betw,een Groups 
Within Groups 
Total 
df 
2 
57 
. 59 
SCHEFFE CONTRAST 
Control 
Short-term 
VENULES: 
ANOVA 
Source of 
Variation 
Between Groups 
Within Groups 
Total 
SCIIEFFE CONTl~i\ST 
df 
.2 
52 
54 
Sum of 
Squares 
2407.25 
12830.00 
15237.20 
Short-term 
9.79 
Sum of 
Squares 
1701. 25 
13535.80 
15237.10 
Short-term 
1. 06 
Sum of 
Squares 
1786.25 
14337.30 
---16123.60 
F Mean· 
Squares 
1203.63 
233.272 
5.1597 
Long-term 
6.17 
0.38 
F He an 
Squares 
850.625 
237.471 
3.5820 
Long-term 
6.92 
3.-02 
F He an 
Squares 
893.125 
275.718 
3.2393 
------------------------------------· 
Control 
Short-term 
Short-term 
-------1.37 
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lJong_:=-Ertn 
6.17 
2.36 
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